Circulation Journal
2012-01-01
Intensive glucose lowering in cardiovascular risk management - unsolved questions - .
Michio Shimabukuro, Hiroaki Masuzaki, Masataka Sata
Index: Circ. J. 76(3) , 593-5, (2012)
Full Text: HTML
Abstract
Related Compounds
Related Articles:
2013-11-01
[Pak. J. Pharm. Sci. 26(6) , 1229-35, (2013)]
From evidence assessments to coverage decisions?: the case example of glinides in Germany.
2012-01-01
[Health Policy 104(1) , 27-31, (2012)]
Nateglinide--current and future role in the treatment of patients with type 2 diabetes mellitus.
2005-10-01
[Int. J. Clin. Pract. 59(10) , 1218-28, (2005)]
2012-02-01
[Diabetes Obes. Metab. 14(2) , 187-9, (2012)]
Nateglinide (Starlix): update on a new antidiabetic agent.
2003-01-01
[Int. J. Clin. Pract. 57(6) , 535-41, (2003)]